All lobbying filings

Aviva Strategies (FKA MGB Consulting)

Aviva Strategies (FKA MGB Consulting) filed a Q4 report for Endeavor Biomedicines on January 15, 2026, reporting $51,000 in lobbying income.

Lobbying for Endeavor Biomedicines · Biotechnology & therapeutics

As filed: AVIVA STRATEGIES (FKA MGB CONSULTING) for ENDEAVOR BIOMEDICINES.

All filings by Aviva Strategies (FKA MGB Consulting) · Everything Endeavor Biomedicines has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 15, 2026

Income

$51,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

FAIR Act FDA Modernization

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.